{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:50:27Z","timestamp":1780084227159,"version":"3.54.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/jpet.102.034744","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:44:00Z","timestamp":1042224240000},"page":"584-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Persistent Suppression of Hepatic CYP2A1 Expression and Serum Triiodothyronine Levels by Tamoxifen in Intact Female Rats: Dose-Response Analysis and Comparison with 4-Hydroxytamoxifen, Fulvestrant (ICI 182,780), and 17\u03b2-Estradiol-3-benzoate"],"prefix":"10.1016","volume":"302","author":[{"given":"Ludger M.","family":"Ickenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelvio M.","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.034744_bib1","first-page":"1031","article-title":"Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A and CYP2A1 expression in adult female rats.","volume":"26","author":"Anderson","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.102.034744_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0003-9861(92)90574-G","article-title":"Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the rat.","volume":"286","author":"Bandiera","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/jpet.102.034744_bib3","first-page":"116","article-title":"90-Day feeding and one-generation reproduction study in Crl:CD BR rats with 17\u03b2-estradiol.","volume":"44","author":"Biegel","year":"1998","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.102.034744_bib4","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/endo.137.8.8754747","article-title":"Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I expression and secretion.","volume":"137","author":"Borski","year":"1996","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1476-5381.1983.tb09411.x","article-title":"The biological activity of a single dose of tamoxifen in the adult ovariectomized rat.","volume":"78","author":"Bowman","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.034744_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-2952(95)02191-4","article-title":"Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2 and steroid 5\u03b1-reductase.","volume":"51","author":"Chang","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.034744_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0090-9556(24)15305-6","article-title":"Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.","volume":"27","author":"Dehal","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.102.034744_bib8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/endo.136.3.7867556","article-title":"Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.","volume":"136","author":"DiPippo","year":"1995","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3565(24)36609-1","article-title":"Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.","volume":"281","author":"DiPippo","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.034744_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/endo-105-2-555","article-title":"Age- and sex-related differences in episodic growth hormone secretion in the rat.","volume":"105","author":"Ed\u00e9n","year":"1979","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(24)37599-8","article-title":"Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.","volume":"286","author":"Fitts","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.034744_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary tumors.","volume":"1","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1124\/jpet.102.034744_bib13","first-page":"3919","article-title":"Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.","volume":"53","author":"Greaves","year":"1993","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.102.034744_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(90)90087-I","article-title":"Endocrine pathology of estrogens: species differences.","volume":"47","author":"Hart","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.102.034744_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2964(76)90030-X","article-title":"Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.","volume":"12","author":"Jordan","year":"1976","journal-title":"Eur J Cancer"},{"key":"10.1124\/jpet.102.034744_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0006-2952(00)00247-1","article-title":"Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9 and CYP3A2.","volume":"59","author":"Kawai","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.034744_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-9556(24)14948-3","article-title":"Modulation of hepatic CYP2A1, CYP2C11 and CYP3A9 expression in adult rats by neonatal administration of tamoxifen.","volume":"27","author":"Kawai","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.102.034744_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0378-4347(95)00530-7","article-title":"Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.","volume":"678","author":"MacCallum","year":"1996","journal-title":"J Chromatogr B"},{"key":"10.1124\/jpet.102.034744_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(24)01358-9","article-title":"Basic guide to the mechanisms of antiestrogen action.","volume":"50","author":"MacGregor","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.034744_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0090-9556(25)07468-9","article-title":"Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.","volume":"21","author":"Mani","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.102.034744_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/carcin\/15.3.439","article-title":"A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism.","volume":"15","author":"Potter","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.102.034744_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-4731(82)90137-6","article-title":"Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics and metabolic activation of the cis and trans isomers of tamoxifen.","volume":"16","author":"Robertson","year":"1982","journal-title":"J Steroid Biochem"},{"key":"10.1124\/jpet.102.034744_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-9556(25)07102-8","article-title":"Metabolites, pharmacodynamics and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.","volume":"19","author":"Robinson","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.102.034744_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/10408440008951120","article-title":"Chemoprevention of breast cancer by tamoxifen: risks and opportunities.","volume":"30","author":"Smith","year":"2000","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/jpet.102.034744_bib25","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1210\/endo.130.6.1350760","article-title":"Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin.","volume":"130","author":"Tannenbaum","year":"1992","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0031-9384(71)90050-3","article-title":"Variations in food and water intake in the normal and acyclic female rat.","volume":"7","author":"Tartellin","year":"1971","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.102.034744_bib27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1210\/endo-103-5-1647","article-title":"Effects of ethynyl estradiol and progesterone on triglyceride metabolism in the female rat.","volume":"103","author":"Valette","year":"1980","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0031-9384(79)90028-3","article-title":"Gonadal effects on food intake and adiposity: a metabolic hypothesis.","volume":"22","author":"Wade","year":"1979","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.102.034744_bib29","first-page":"R1392","article-title":"Tamoxifen mimics the effects of estradiol on food intake, body weight and body composition in rats.","volume":"264","author":"Wade","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.102.034744_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-4731(88)90086-6","article-title":"Biology and mode of action of pure antiestrogens.","volume":"30","author":"Wakeling","year":"1988","journal-title":"J Steroid Biochem"},{"key":"10.1124\/jpet.102.034744_bib31","first-page":"3867","article-title":"A potent specific pure antiestrogen with clinical potential.","volume":"51","author":"Wakeling","year":"1991","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.102.034744_bib32","series-title":"Cytochrome P450: Structure, Mechanism and Biochemistry","first-page":"391","article-title":"Hormonal regulation of liver cytochrome P450 enzymes","author":"Waxman","year":"1995"},{"key":"10.1124\/jpet.102.034744_bib33","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1210\/endo-124-6-2954","article-title":"Female-predominant rat hepatic P-450 forms j (IIE1) and 3 (IIA1) are under hormonal regulatory controls distinct from those of the sex-specific P-450 forms.","volume":"124","author":"Waxman","year":"1989","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.034744_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-2952(93)90372-4","article-title":"Induction of CYP2B1 and 3A1 and associated monooxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.","volume":"45","author":"White","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.034744_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0006-2952(96)00355-3","article-title":"Inductive effect of Telazol\u00ae on hepatic expression of cytochrome P450 2B in rats.","volume":"52","author":"Wong","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.034744_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/oxfordjournals.jbchem.a123249","article-title":"Modulation of hepatic level of microsomal testosterone 7\u03b1-hydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver.","volume":"108","author":"Yamazoe","year":"1990","journal-title":"J Biochem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.034744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:24:11Z","timestamp":1740007451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524358033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0022356524358033"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.034744","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent Suppression of Hepatic CYP2A1 Expression and Serum Triiodothyronine Levels by Tamoxifen in Intact Female Rats: Dose-Response Analysis and Comparison with 4-Hydroxytamoxifen, Fulvestrant (ICI 182,780), and 17\u03b2-Estradiol-3-benzoate","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.034744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}